Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00934479 · ClinicalTrials.gov registry record · Phase 1
Intestinal Microecology in Chronic Constipation
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00934479: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT00934479 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00934479, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the bacteria normally present in the bowels are different in people with constipation and to see what effect the treatment with the Food and Drug Administration (FDA) - approved drug, lubiprostone, has on these bacteria.
Interventions
- DRUG Lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00934479
The ClinicalTrials.gov registry entry for NCT00934479 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lubiprostone is the first listed.
NCT00934479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00934479 about?
NCT00934479 is a clinical study titled "Intestinal Microecology in Chronic Constipation". The purpose of this study is to determine whether the bacteria normally present in the bowels are different in people with constipation and to see what effect the treatment with the Food and Drug Administration (FDA) - approved drug, lubiprostone, has on these bacteria.
What is the current status of trial NCT00934479?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2010-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00934479?
The interventions under investigation include: Lubiprostone (DRUG).
Who is sponsoring clinical trial NCT00934479?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.